Prenatal	prenatal	O	O
dexamethasone	dexamethasone	S_chemicals	O
programs	programs	O	O
hypertension	hypertension	O	S_disease
and	and	O	O
renal	renal	O	B_disease
injury	injury	O	S_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

Dexamethasone	dexamethasone	S_chemicals	O
is	is	O	O
frequently	frequently	O	O
administered	administered	O	O
to	to	O	O
the	the	O	O
developing	developing	O	O
fetus	fetus	O	O
to	to	O	O
accelerate	accelerate	O	O
pulmonary	pulmonary	O	O
development	development	O	O
.	.	O	O

The	the	O	O
purpose	purpose	O	O
of	of	O	O
the	the	O	O
present	present	O	O
study	study	O	O
was	was	O	O
to	to	O	O
determine	determine	O	O
if	if	O	O
prenatal	prenatal	O	O
dexamethasone	dexamethasone	S_chemicals	O
programmed	programmed	O	O
a	a	O	O
progressive	progressive	O	O
increase	increase	O	O
in	in	O	O
blood	blood	O	B_disease
pressure	pressure	O	I_disease
and	and	O	O
renal	renal	O	B_disease
injury	injury	O	S_disease
in	in	O	O
rats	rats	O	O
.	.	O	O

Pregnant	pregnant	O	O
rats	rats	O	O
were	were	O	O
given	given	O	O
either	either	O	O
vehicle	vehicle	O	O
or	or	O	O
2	2	O	O
daily	daily	O	O
intraperitoneal	intraperitoneal	O	O
injections	injections	O	O
of	of	O	O
dexamethasone	dexamethasone	S_chemicals	O
(	(	O	O
0.2	0.2	O	O
mg/kg	mg/kg	O	O
body	body	O	B_disease
weight	weight	O	I_disease
)	)	O	O
on	on	O	O
gestational	gestational	O	O
days	days	O	O
11	11	O	O
and	and	O	O
12	12	O	O
,	,	O	O
13	13	O	O
and	and	O	O
14	14	O	O
,	,	O	O
15	15	O	O
and	and	O	O
16	16	O	O
,	,	O	O
17	17	O	O
and	and	O	O
18	18	O	O
,	,	O	O
or	or	O	O
19	19	O	O
and	and	O	O
20	20	O	O
.	.	O	O

Offspring	offspring	O	O
of	of	O	O
rats	rats	O	O
administered	administered	O	O
dexamethasone	dexamethasone	S_chemicals	O
on	on	O	O
days	days	O	O
15	15	O	O
and	and	O	O
16	16	O	O
gestation	gestation	O	O
had	had	O	O
a	a	O	O
20	20	O	O
%	%	O	O
reduction	reduction	O	O
in	in	O	O
glomerular	glomerular	O	O
number	number	O	O
compared	compared	O	O
with	with	O	O
control	control	O	O
at	at	O	O
6	6	O	O
to	to	O	O
9	9	O	O
months	months	O	O
of	of	O	O
age	age	O	O
(	(	O	O
22	22	O	O
527+/-509	527+/-509	O	O
versus	versus	O	O
28	28	O	O
050+/-561	050+/-561	O	O
,	,	O	O
P<0.05	p<0.05	O	O
)	)	O	O
,	,	O	O
which	which	O	O
was	was	O	O
comparable	comparable	O	O
to	to	O	O
the	the	O	O
percent	percent	O	O
reduction	reduction	O	O
in	in	O	O
glomeruli	glomeruli	O	O
measured	measured	O	O
at	at	O	O
3	3	O	O
weeks	weeks	O	O
of	of	O	O
age	age	O	O
.	.	O	O

Six-	six-	O	O
to	to	O	O
9-month	9-month	O	O
old	old	O	O
rats	rats	O	O
receiving	receiving	O	O
prenatal	prenatal	O	O
dexamethasone	dexamethasone	S_chemicals	O
on	on	O	O
days	days	O	O
17	17	O	O
and	and	O	O
18	18	O	O
of	of	O	O
gestation	gestation	O	O
had	had	O	O
a	a	O	O
17	17	O	O
%	%	O	O
reduction	reduction	O	O
in	in	O	O
glomeruli	glomeruli	O	O
(	(	O	O
23	23	O	O
380+/-587	380+/-587	O	O
)	)	O	O
compared	compared	O	O
with	with	O	O
control	control	O	O
rats	rats	O	O
(	(	O	O
P<0.05	p<0.05	O	O
)	)	O	O
.	.	O	O

Male	male	O	O
rats	rats	O	O
that	that	O	O
received	received	O	O
prenatal	prenatal	O	O
dexamethasone	dexamethasone	S_chemicals	O
on	on	O	O
days	days	O	O
15	15	O	O
and	and	O	O
16	16	O	O
,	,	O	O
17	17	O	O
and	and	O	O
18	18	O	O
,	,	O	O
and	and	O	O
13	13	O	O
and	and	O	O
14	14	O	O
of	of	O	O
gestation	gestation	O	O
had	had	O	O
elevated	elevated	O	O
blood	blood	O	B_disease
pressures	pressures	O	I_disease
at	at	O	O
6	6	O	O
months	months	O	O
of	of	O	O
age	age	O	O
;	;	O	O
the	the	O	O
latter	latter	O	O
group	group	O	O
did	did	O	O
not	not	O	O
have	have	O	O
a	a	O	O
reduction	reduction	O	O
in	in	O	O
glomerular	glomerular	O	O
number	number	O	O
.	.	O	O

Adult	adult	O	O
rats	rats	O	O
given	given	O	O
dexamethasone	dexamethasone	S_chemicals	O
on	on	O	O
days	days	O	O
15	15	O	O
and	and	O	O
16	16	O	O
of	of	O	O
gestation	gestation	O	O
had	had	O	O
more	more	O	O
glomeruli	glomeruli	O	O
with	with	O	O
glomerulosclerosis	glomerulosclerosis	O	S_disease
than	than	O	O
control	control	O	O
rats	rats	O	O
.	.	O	O

This	this	O	O
study	study	O	O
shows	shows	O	O
that	that	O	O
prenatal	prenatal	O	O
dexamethasone	dexamethasone	S_chemicals	O
in	in	O	O
rats	rats	O	O
results	results	O	O
in	in	O	O
a	a	O	O
reduction	reduction	O	O
in	in	O	O
glomerular	glomerular	O	O
number	number	O	O
,	,	O	O
glomerulosclerosis	glomerulosclerosis	O	S_disease
,	,	O	O
and	and	O	O
hypertension	hypertension	O	S_disease
when	when	O	O
administered	administered	O	O
at	at	O	O
specific	specific	O	O
points	points	O	O
during	during	O	O
gestation	gestation	O	O
.	.	O	O

Hypertension	hypertension	O	S_disease
was	was	O	O
observed	observed	O	O
in	in	O	O
animals	animals	O	O
that	that	O	O
had	had	O	O
a	a	O	O
reduction	reduction	O	O
in	in	O	O
glomeruli	glomeruli	O	O
as	as	O	O
well	well	O	O
as	as	O	O
in	in	O	O
a	a	O	O
group	group	O	O
that	that	O	O
did	did	O	O
not	not	O	O
have	have	O	O
a	a	O	O
reduction	reduction	O	O
in	in	O	O
glomerular	glomerular	O	O
number	number	O	O
,	,	O	O
suggesting	suggesting	O	O
that	that	O	O
a	a	O	O
reduction	reduction	O	O
in	in	O	O
glomerular	glomerular	O	O
number	number	O	O
is	is	O	O
not	not	O	O
the	the	O	O
sole	sole	O	O
cause	cause	O	O
for	for	O	O
the	the	O	O
development	development	O	O
of	of	O	O
hypertension	hypertension	O	S_disease
.	.	O	O

